Brokerages expect that Abiomed, Inc. (NASDAQ:ABMD – Get Rating) will report earnings of $1.09 per share for the current quarter, according to Zacks. Six analysts have provided estimates for Abiomed’s earnings, with the lowest EPS estimate coming in at $1.01 and the highest estimate coming in at $1.28. Abiomed reported earnings per share of $1.24 […]
Voloridge Investment Management LLC acquired a new position in shares of Abiomed, Inc. (NASDAQ:ABMD – Get Rating) during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 5,170 shares of the medical equipment provider’s stock, valued at approximately $1,683,000. A number of […]